NCT01813305View on ClinicalTrials.gov

CSTC1 for Diabetic Foot Ulcers Phase II Study

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

July 9, 2014

Primary Completion Date

January 7, 2020

Study Completion Date

January 7, 2020

Conditions
Diabetic Foot UlcerDiabetes MellitusWounds
Interventions
DRUG

CSTC1

vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof

DRUG

CSTC1 Matched vehicle

Trial Locations (1)

Unknown

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Sponsors
All Listed Sponsors
collaborator

ASKLEP Inc.

INDUSTRY

lead

Charsire Biotechnology Corp.

INDUSTRY